Back
40
Day Range
$30.51
$32.19
52-Week Range
$21.73
$35.00
Volume
181,998
50D / 200D Avg
$31.17
/
$27.30
Prev Close
$31.05
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 36.8 | 0.4 |
| P/B | 3.3 | 2.9 |
| ROE % | 9.5 | 3.8 |
| Net Margin % | 3.1 | 3.9 |
| Rev Growth 5Y % | 21.2 | 10.0 |
| D/E | 1.4 | 0.2 |
Analyst Price Target
Hold
$39.00
+24.3%
Low: $38.00
High: $40.00
Forward P/E
23.9
Forward EPS
$1.31
EPS Growth (est.)
+0.0%
Est. Revenue
1.2 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$1.92
$1.91 – $1.92
|
1.3 B | 2 |
| FY2027 |
$1.57
$1.53 – $1.58
|
1.2 B | 4 |
| FY2026 |
$1.31
$1.25 – $1.35
|
1.2 B | 4 |
Key Takeaways
Revenue grew 21.17% annually over 5 years — strong growth
Earnings grew 31.11% over the past year
Generating 26.30M in free cash flow
P/E of 36.76 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 15.14%
Cash machine — converts 88.90% of earnings into free cash flow
Growth
Revenue Growth (5Y)
21.17%
Revenue (1Y)36.31%
Earnings (1Y)31.11%
FCF Growth (3Y)2.59%
Quality
Return on Equity
9.45%
ROIC4.91%
Net Margin3.12%
Op. Margin5.42%
Safety
Debt / Equity
1.36
Current Ratio1.14
Interest Coverage7.70
Valuation
P/E Ratio
36.76
P/B Ratio3.27
EV/EBITDA29.65
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 36.31% | Revenue Growth (3Y) | 31.88% |
| Earnings Growth (1Y) | 31.11% | Earnings Growth (3Y) | 48.69% |
| Revenue Growth (5Y) | 21.17% | Earnings Growth (5Y) | 82.00% |
| Profitability | |||
| Revenue (TTM) | 947.71M | Net Income (TTM) | 29.58M |
| ROE | 9.45% | ROA | 3.06% |
| Gross Margin | 12.92% | Operating Margin | 5.42% |
| Net Margin | 3.12% | Free Cash Flow (TTM) | 26.30M |
| ROIC | 4.91% | FCF Growth (3Y) | 2.59% |
| Safety | |||
| Debt / Equity | 1.36 | Current Ratio | 1.14 |
| Interest Coverage | 7.70 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 36.76 | P/B Ratio | 3.27 |
| P/S Ratio | 1.15 | PEG Ratio | 1.69 |
| EV/EBITDA | 29.65 | Dividend Yield | 0.00% |
| Market Cap | 1.09B | Enterprise Value | 1.52B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 947.71M | 695.24M | 544.89M | 473.24M | 439.69M |
| Net Income | 29.58M | 22.56M | 13.38M | 6.64M | 2.70M |
| EPS (Diluted) | 0.84 | 0.71 | 0.44 | 0.22 | 0.07 |
| Gross Profit | 122.47M | 93.76M | 67.04M | 58.59M | 48.60M |
| Operating Income | 51.39M | 38.12M | 25.17M | 12.74M | 4.70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 968.18M | 679.52M | 539.69M | 512.12M | 530.30M |
| Total Liabilities | 593.93M | 367.56M | 394.18M | 386.46M | 416.05M |
| Shareholders' Equity | 332.60M | 293.28M | 140.34M | 121.01M | 110.20M |
| Total Debt | 453.16M | 273.09M | 329.63M | 326.57M | 355.24M |
| Cash & Equivalents | 17.02M | 24.25M | 6.06M | 2.08M | 5.19M |
| Current Assets | 167.41M | 122.86M | 80.08M | 73.82M | 75.84M |
| Current Liabilities | 147.26M | 101.70M | 71.55M | 70.25M | 71.64M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#84 of 146
Recent Activity
Entered
Full Throttle
Mar 24, 2026